Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.028 | 0.6352 | 0.5 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0376 | 1 | 1 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0376 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0114 | 0 | 0.5 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0376 | 1 | 1 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.028 | 0.6352 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.028 | 0.6352 | 0.1401 |
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0376 | 1 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.028 | 0.6352 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 2000 uM | Inhibition potency against Cholecystokinin-8-Inactivating Peptidase (Serine Peptidase). | ChEMBL. | 10691692 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.